These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37894473)

  • 21. The Role of CAR-T Cells in Peritoneal Carcinomatosis from Gastric Cancer: Rationale, Experimental Work, and Clinical Applications.
    Qian S; Villarejo-Campos P; García-Olmo D
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yield of peritoneal cytology in staging patients with gastric and gastroesophageal cancer.
    Allen CJ; Newhook TE; Vreeland TJ; Das P; Minsky BD; Blum M; Song S; Ajani J; Ikoma N; Mansfield PF; Roy-Chowdhuri S; Badgwell BD
    J Surg Oncol; 2019 Dec; 120(8):1350-1357. PubMed ID: 31612494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Senescent Tumor Cells in the Peritoneal Carcinomatosis Drive Immunosenescence in the Tumor Microenvironment.
    Braumüller H; Mauerer B; Berlin C; Plundrich D; Marbach P; Cauchy P; Laessle C; Biesel E; Holzner PA; Kesselring R
    Front Immunol; 2022; 13():908449. PubMed ID: 35844581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy of endostar combined with chemotherapy in the treatment of peritoneal carcinomatosis in gastric cancer: results from a retrospective study.
    Yao J; Fan L; Peng C; Huang A; Liu T; Lin Z; Yang Q; Zhang T; Ma H
    Oncotarget; 2017 Sep; 8(41):70788-70797. PubMed ID: 29050319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraperitoneal therapy for gastric cancer peritoneal carcinomatosis.
    Harada K; Yamashita K; Iwatsuki M; Baba H; Ajani JA
    Expert Rev Clin Pharmacol; 2022 Jan; 15(1):43-49. PubMed ID: 35184625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer.
    Nasser S; Babayeva A; Braicu I; Richter R; Bilir E; Chekerov R; Muallem MZ; Pietzner K; Inci MG; Sehouli J
    Front Oncol; 2022; 12():1014073. PubMed ID: 36620574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum.
    Lemoine L; Sugarbaker P; Van der Speeten K
    World J Gastroenterol; 2016 Sep; 22(34):7692-707. PubMed ID: 27678351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of cytoreduction and hyperthermic intraperitoneal chemotherapy for metastatic gastroesophageal junction adenocarcinoma?
    Zaidi SMH; Ho K; Sohail AH; Whittington J
    J Surg Case Rep; 2023 Dec; 2023(12):rjad664. PubMed ID: 38076311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraperitoneal free cancer cells in gastric cancer: pathology of peritoneal carcinomatosis and rationale for intraperitoneal chemotherapy/hyperthermic intraperitoneal chemotherapy in gastric cancer.
    Ji ZH; Peng KW; Li Y
    Transl Gastroenterol Hepatol; 2016; 1():69. PubMed ID: 28138635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraperitoneal chemotherapy for locally advanced gastric cancer to prevent and treat peritoneal carcinomatosis.
    Liang H
    Transl Gastroenterol Hepatol; 2016; 1():62. PubMed ID: 28138628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis.
    Rihuete Caro C; Manzanedo I; Pereira F; Carrion-Alvarez L; Serrano Á; Pérez-Viejo E
    Eur J Surg Oncol; 2018 Nov; 44(11):1805-1810. PubMed ID: 30087071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune checkpoint inhibitors for treatment of advanced gastric or gastroesophageal junction cancer: Current evidence and future perspectives.
    Zhang Z; Xie T; Zhang X; Qi C; Shen L; Peng Z
    Chin J Cancer Res; 2020 Jun; 32(3):287-302. PubMed ID: 32694895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy - PIPAC-OPC2.
    Graversen M; Detlefsen S; Asmussen J; Mahdi B; Fristrup C; Pfeiffer P; Mortensen MB
    Pleura Peritoneum; 2018 Jun; 3(2):20180108. PubMed ID: 30911656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does upfront therapy with cytoreductive surgery and HIPEC confer a survival benefit in patients with synchronous gastric peritoneal carcinomatosis when compared with patients with metachronous gastric peritoneal carcinomatosis?
    Kopanakis N; Efstathiou E; Sarris D; Spiliotis J
    J BUON; 2017; 22(5):1144-1147. PubMed ID: 29135095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritoneal carcinomatosis from colorectal cancer: HIPEC?
    Confuorto G; Giuliano ME; Grimaldi A; Viviano C
    Surg Oncol; 2007 Dec; 16 Suppl 1():S149-52. PubMed ID: 18257149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperthermic intraperitoneal chemotherapy for gastric cancer: a narrative review.
    Chen C; Justo M; Gangi A
    Chin Clin Oncol; 2023 Dec; 12(6):68. PubMed ID: 38195075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer.
    Dong X; Fan J; Xie W; Wu X; Wei J; He Z; Wang W; Wang X; Shen P; Bei Y
    Br J Cancer; 2023 Aug; 129(3):551-562. PubMed ID: 37386139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of cytoreductive surgery and intraperitoneal chemotherapy in gastric cancer.
    Young S; Ostowari A; Yu J; Eng OS; Dayyani F; Senthil M
    Clin Adv Hematol Oncol; 2022 Nov; 20(11):673-682. PubMed ID: 36331405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of patients and staging of peritoneal surface malignancies.
    Cotte E; Passot G; Gilly FN; Glehen O
    World J Gastrointest Oncol; 2010 Jan; 2(1):31-5. PubMed ID: 21160814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune profile of patients with peritoneal carcinomatosis selected for CRS-HIPEC therapy.
    Kleber J; Yang Zhou J; Weber F; Bitterer F; Hauer P; Kupke P; Kronenberg K; Geissler EK; Schlitt HJ; Hornung M; Hutchinson JA; Werner JM
    Cancer Immunol Immunother; 2023 Nov; 72(11):3867-3873. PubMed ID: 37580610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.